Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SARL SPFPL DE PHARMACIEN D'OFFICINE GERMAIN : revenue, balance sheet and financial ratios

SARL SPFPL DE PHARMACIEN D'OFFICINE GERMAIN is a French company founded 8 years ago, specialized in the sector Supports juridiques de gestion de patrimoine immobilier. Based in SAINT-JEAN-LE-BLANC (45650), this company of category PME shows in 2025 a net income positive of 28 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SARL SPFPL DE PHARMACIEN D'OFFICINE GERMAIN (SIREN 833786783)
Indicator 2025 2024 2023 2022 2021 2020 2019 2018
Revenue N/C N/C N/C N/C N/C N/C N/C N/C
Net income 28 413 € 21 243 € 13 985 € 7 368 € 657 € 325 € -170 € 4 111 €
EBITDA -2 702 € -2 269 € -2 758 € -2 607 € -1 356 € -1 480 € -1 741 € -6 726 €
Net margin N/C N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2025, SARL SPFPL DE PHARMACIEN D'OFFICINE GERMAIN generates positive net income of 28 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2025: 4 k€ -> 28 k€.

EBITDA (2025) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

-2 702 €

EBIT (2025) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

4 679 €

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

28 413 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 51%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 31%. The balance between equity and debt is satisfactory. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 2.5 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

50.947%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

30.59%

Repayment capacity (2025) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

2.522

Solvency indicators evolution
SARL SPFPL DE PHARMACIEN D'OFFICINE GERMAIN

Sector positioning

Debt ratio
50.95 2025
2023
2024
2025
Q1: 0.0
Med: 20.52
Q3: 65.11
Average

In 2025, the debt ratio of SARL SPFPL DE PHARMACIEN ... (50.95) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
30.59% 2025
2023
2024
2025
Q1: 4.62%
Med: 41.48%
Q3: 82.54%
Average -20 pts over 3 years

In 2025, the financial autonomy of SARL SPFPL DE PHARMACIEN ... (30.6%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
2.52 years 2025
2023
2024
2025
Q1: 0.0 years
Med: 0.51 years
Q3: 3.44 years
Average -8 pts over 3 years

In 2025, the repayment capacity of SARL SPFPL DE PHARMACIEN ... (2.52) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 407.20. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

407.205

Interest coverage (2025) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

-52.073

Liquidity indicators evolution
SARL SPFPL DE PHARMACIEN D'OFFICINE GERMAIN

Sector positioning

Liquidity ratio
407.2 2025
2023
2024
2025
Q1: 205.14
Med: 718.12
Q3: 3915.76
Average -40 pts over 3 years

In 2025, the liquidity ratio of SARL SPFPL DE PHARMACIEN ... (407.20) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
-52.07x 2025
2023
2024
2025
Q1: -22.33x
Med: 0.0x
Q3: 0.0x
Watch

In 2025, the interest coverage of SARL SPFPL DE PHARMACIEN ... (-52.1x) ranks in the bottom 25% of the sector. This ratio indicates how many times operating income covers interest expenses. Low coverage may indicate fragility to rate or income variations.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 78 days. Excellent situation: suppliers finance 78 days of the operating cycle (retail model).

Operating WCR (2025) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2025) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2025) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

78 j

Inventory turnover (2025) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SARL SPFPL DE PHARMACIEN D'OFFICINE GERMAIN

Positioning of SARL SPFPL DE PHARMACIEN D'OFFICINE GERMAIN in its sector

Comparison with sector Supports juridiques de gestion de patrimoine immobilier

Valuation estimate

Based on 277 transactions of similar company sales (all years), the value of SARL SPFPL DE PHARMACIEN D'OFFICINE GERMAIN is estimated at 63 402 € (range 14 248€ - 195 209€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
14k€ 63k€ 195k€
63 402 € Range: 14 248€ - 195 209€
NAF 5 all-time

Valuation method used

Net Income Multiple
28 413 € × 2.2x = 63 402 €
Range: 14 249€ - 195 209€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Supports juridiques de gestion de patrimoine immobilier)

Compare SARL SPFPL DE PHARMACIEN D'OFFICINE GERMAIN with other companies in the same sector:

Voir toutes les statistiques du secteur Supports juridiques de gestion de patrimoine immobilier

Frequently asked questions about SARL SPFPL DE PHARMACIEN D'OFFICINE GERMAIN

What is the revenue of SARL SPFPL DE PHARMACIEN D'OFFICINE GERMAIN ?

The revenue of SARL SPFPL DE PHARMACIEN D'OFFICINE GERMAIN is not publicly disclosed (confidential accounts filed with INPI).

Is SARL SPFPL DE PHARMACIEN D'OFFICINE GERMAIN profitable?

Yes, SARL SPFPL DE PHARMACIEN D'OFFICINE GERMAIN generated a net profit of 28 k€ in 2025.

Where is the headquarters of SARL SPFPL DE PHARMACIEN D'OFFICINE GERMAIN ?

The headquarters of SARL SPFPL DE PHARMACIEN D'OFFICINE GERMAIN is located in SAINT-JEAN-LE-BLANC (45650), in the department Loiret.

Where to find the tax return of SARL SPFPL DE PHARMACIEN D'OFFICINE GERMAIN ?

The tax return of SARL SPFPL DE PHARMACIEN D'OFFICINE GERMAIN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SARL SPFPL DE PHARMACIEN D'OFFICINE GERMAIN operate?

SARL SPFPL DE PHARMACIEN D'OFFICINE GERMAIN operates in the sector Supports juridiques de gestion de patrimoine immobilier (NAF code 68.32B). See the 'Sector positioning' section above to compare the company with its competitors.